5M Triggiani, V Patella, R I Staino, et al. Allergy and the cardiovascular system [J]. Clinical and Experimental Immunology, 2008, 153 (Suppl 1 ): 7-11.
6H Henmar, G Lund, L Lund, et al. Allergenicity, immunogeniciy and dose-relationshi of three intact allergen vaccines and four al lergoid vaccines for subcutaneous grass pollen immunotherapy [J]. Clinical and Experimental Immunologr, 2008, 153 (3) : 316-323.
7Pool V, Braun MM, Kelso JM, et al. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States [J]. Pediatrics, 2002, 110 (6): 71.
8Patja A, Davidkin I, Kurki T, et al. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up[J]. Pediatrics Infect Dis J, 2000, 19(12) : 1127-1134.
9Bohlke K, Davis RL, Marcy SM, et al. Risk of Anaphylaxis after Vaccination of Children and Adolescents[J]. Pediatrics, 2003, 112(4) : 815-820.
10BISSET LR,SCHMID-GRENDELMEIER P.Chemokines and their receptors in the pathogenesis of allergic asthma:progress and perspective[J].Curr Opin Pulm Med,2005,11(1):35-42.
